HK1156077A1 - Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides - Google Patents
Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptidesInfo
- Publication number
- HK1156077A1 HK1156077A1 HK11110367.1A HK11110367A HK1156077A1 HK 1156077 A1 HK1156077 A1 HK 1156077A1 HK 11110367 A HK11110367 A HK 11110367A HK 1156077 A1 HK1156077 A1 HK 1156077A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- urlc10
- lung cancers
- peptide vaccines
- cancers expressing
- expressing ttk
- Prior art date
Links
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 229940023041 peptide vaccine Drugs 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
- C12N9/1211—Thymidine kinase (2.7.1.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65685705P | 2005-02-25 | 2005-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1156077A1 true HK1156077A1 (en) | 2012-06-01 |
Family
ID=36570330
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11110363.5A HK1156076A1 (en) | 2005-02-25 | 2011-09-30 | Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides |
HK11110367.1A HK1156077A1 (en) | 2005-02-25 | 2011-09-30 | Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11110363.5A HK1156076A1 (en) | 2005-02-25 | 2011-09-30 | Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides |
Country Status (10)
Country | Link |
---|---|
US (2) | US7847060B2 (pt) |
EP (3) | EP2325306B1 (pt) |
JP (5) | JP4461179B2 (pt) |
DE (1) | DE602006021283D1 (pt) |
DK (2) | DK2325306T3 (pt) |
ES (3) | ES2459466T3 (pt) |
HK (2) | HK1156076A1 (pt) |
PL (2) | PL2325306T3 (pt) |
PT (2) | PT2325305E (pt) |
WO (1) | WO2006090810A2 (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200413725A (en) * | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
EP2468887A1 (en) * | 2006-12-13 | 2012-06-27 | Oncotherapy Science, Inc. | TTK as tumor marker and therapeutic target for lung cancer |
TWI610939B (zh) | 2007-02-21 | 2018-01-11 | 腫瘤療法 科學股份有限公司 | 表現腫瘤相關抗原之癌症的胜肽疫苗 |
AU2012261725B2 (en) * | 2007-02-21 | 2014-11-27 | Oncotherapy Science, Inc. | Peptide vaccines for cancers expressing tumor-associated antigens |
EP2185732A1 (en) * | 2007-07-30 | 2010-05-19 | Oncotherapy Science, Inc. | Cancer associated gene ly6k |
ES2632123T3 (es) | 2007-08-20 | 2017-09-11 | Oncotherapy Science, Inc. | Péptido CDH3 y agente medicinal que comprende el mismo |
TWI543767B (zh) * | 2008-08-19 | 2016-08-01 | 腫瘤療法 科學股份有限公司 | Hig2與urlc10抗原決定位胜肽以及含此胜肽之疫苗 |
TW201008574A (en) | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
RU2532105C2 (ru) | 2008-10-22 | 2014-10-27 | Онкотерапи Сайенс, Инк. | Эпитопные пептиды rab6kifl/kif20a и содержащие их вакцины |
TWI500932B (zh) * | 2008-12-05 | 2015-09-21 | Oncotherapy Science Inc | Wdrpuh抗原決定位胜肽以及含此胜肽之疫苗 |
CN102333867B (zh) | 2008-12-24 | 2015-01-14 | 肿瘤疗法科学股份有限公司 | C1orf59肽及包含它的疫苗 |
MX2011008917A (es) * | 2009-03-04 | 2011-09-09 | Oncotherapy Science Inc | Peptidos vangl1 y vacunas que incluyen los mismos. |
TW201100090A (en) * | 2009-04-01 | 2011-01-01 | Oncotherapy Science Inc | C6orf167 peptides and vaccines containing the same |
TW201102081A (en) * | 2009-05-11 | 2011-01-16 | Oncotherapy Science Inc | TTK peptides and vaccines including the same |
HUE037593T2 (hu) * | 2009-09-03 | 2018-09-28 | Toray Industries | Immunitásindukáló |
TW201124530A (en) * | 2009-12-01 | 2011-07-16 | Oncotherapy Science Inc | IMP-3 oligopeptides and vaccines including the same |
TW201200525A (en) * | 2009-12-04 | 2012-01-01 | Oncotherapy Science Inc | MYBL2 peptides and vaccines containing the same |
TW201211250A (en) * | 2010-09-07 | 2012-03-16 | Oncotherapy Science Inc | VANGL1 peptides and vaccines including the same |
JP6159996B2 (ja) * | 2012-03-09 | 2017-07-12 | 株式会社富士薬品 | ペプチドを含む医薬組成物 |
JP6255594B2 (ja) * | 2012-07-10 | 2018-01-10 | オンコセラピー・サイエンス株式会社 | Th1細胞のLY6Kエピトープペプチドおよびこれを含有するワクチン |
TWI627182B (zh) | 2013-05-24 | 2018-06-21 | 腫瘤療法 科學股份有限公司 | 對於th1細胞之imp-3抗原決定位胜肽及含此之疫苗 |
KR20220165831A (ko) * | 2014-08-04 | 2022-12-15 | 온코세라피 사이언스 가부시키가이샤 | Urlc10-유래 펩티드 및 이를 포함하는 백신 |
CN111925414A (zh) * | 2014-08-04 | 2020-11-13 | 肿瘤疗法科学股份有限公司 | Koc1衍生的肽和包含它们的疫苗 |
US20180200325A1 (en) * | 2014-11-18 | 2018-07-19 | Shionogi & Co., Ltd. | Stabilized peptide composition |
WO2021060343A1 (ja) * | 2019-09-24 | 2021-04-01 | オンコセラピー・サイエンス株式会社 | Urlc10由来ペプチドまたはdepdc1由来ペプチドを認識するヒトt細胞が発現するt細胞受容体 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5804566A (en) | 1993-08-26 | 1998-09-08 | The Regents Of The University Of California | Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
US5922687A (en) | 1995-05-04 | 1999-07-13 | Board Of Trustees Of The Leland Stanford Junior University | Intracellular delivery of nucleic acids using pressure |
DE69635895D1 (de) | 1995-08-03 | 2006-05-04 | Rijksuniversiteit Te Leiden Le | Antigen presentierende bläschen, die von zellen ableiten |
US5853719A (en) | 1996-04-30 | 1998-12-29 | Duke University | Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
US6294378B1 (en) | 1996-07-26 | 2001-09-25 | Sloan-Kettering Institute For Cancer Research | Method and reagents for genetic immunization |
EP1007671B1 (de) | 1997-04-07 | 2002-02-13 | Roche Diagnostics GmbH | Fanconi-gen ii |
ATE213268T1 (de) | 1997-04-07 | 2002-02-15 | Roche Diagnostics Gmbh | Fanconi-gen ii |
FR2766205B1 (fr) | 1997-07-16 | 2002-08-30 | Inst Nat Sante Rech Med | Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede |
US6255055B1 (en) | 1998-03-09 | 2001-07-03 | Wisconsin Alumni Research Foundation | c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence |
US20030236209A1 (en) * | 1998-03-18 | 2003-12-25 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US20030045491A1 (en) | 2001-02-23 | 2003-03-06 | Christoph Reinhard | TTK in diagnosis and as a therapeutic target in cancer |
AU2001251084A1 (en) | 2000-03-29 | 2001-10-08 | Diadexus, Inc. | Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer |
EP1474528A4 (en) | 2000-10-13 | 2006-06-14 | Protein Design Labs Inc | METHODS FOR DIAGNOSING PROSTATE CANCER, COMPOSITIONS AND METHODS FOR SCREENING PROSTATE CANCER MODULATORS |
CA2427858A1 (en) * | 2000-11-03 | 2002-05-10 | University Of Vermont And State Agricultural College | Compositions for inhibiting grb7 |
JP4429604B2 (ja) | 2001-02-21 | 2010-03-10 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 診断におけるttkおよび癌における治療標的としてのttk |
JP2005527180A (ja) | 2001-04-18 | 2005-09-15 | プロテイン デザイン ラブス, インコーポレイテッド | 肺がんの診断方法、肺がんの修飾因子の組成及びスクリーニングの方法 |
US7189507B2 (en) * | 2001-06-18 | 2007-03-13 | Pdl Biopharma, Inc. | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
CA2460283A1 (en) | 2001-10-31 | 2003-05-08 | Pfizer Products Inc. | Therapeutics and diagnostics for disorders of erythropoiesis |
JP2005525789A (ja) | 2001-11-13 | 2005-09-02 | プロテイン デザイン ラブス インコーポレイティド | ガンの診断方法、ガンのモジュレータのスクリーニング組成物及び方法 |
US20030232350A1 (en) * | 2001-11-13 | 2003-12-18 | Eos Biotechnology, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
WO2003042661A2 (en) | 2001-11-13 | 2003-05-22 | Protein Design Labs, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
JP2005523688A (ja) | 2002-01-18 | 2005-08-11 | ブリストル−マイヤーズ スクイブ カンパニー | タンパク質チロシンキナーゼおよび/またはタンパク質チロシンキナーゼ経路と相互作用する化合物の活性を予測するためのポリヌクレオチドおよびポリペプチドの同定 |
CN101613406A (zh) * | 2002-06-06 | 2009-12-30 | 肿瘤疗法科学股份有限公司 | 与人结肠癌相关的基因和多肽 |
ATE531729T1 (de) | 2002-09-12 | 2011-11-15 | Oncotherapy Science Inc | Kdr-peptide und diese enthaltende impfstoffe |
US20060024692A1 (en) | 2002-09-30 | 2006-02-02 | Oncotherapy Science, Inc. | Method for diagnosing non-small cell lung cancers |
TW200413725A (en) | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
CA2528094A1 (en) | 2003-06-09 | 2005-01-13 | Corixa Corporation | Expression vectors for stimulating an immune response to cancer antigens |
WO2005073374A1 (ja) | 2004-01-29 | 2005-08-11 | Dainippon Sumitomo Pharma Co., Ltd. | 新規腫瘍抗原蛋白質及びその利用 |
EP1584684A1 (en) | 2004-02-20 | 2005-10-12 | Samsung Electronics Co., Ltd. | Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene |
ATE496142T1 (de) | 2004-03-23 | 2011-02-15 | Oncotherapy Science Inc | Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs |
CA2599875A1 (en) | 2005-03-03 | 2006-09-08 | Takeda Pharmaceutical Company Limited | Preventive/therapeutic agent for cancer |
EP2468887A1 (en) | 2006-12-13 | 2012-06-27 | Oncotherapy Science, Inc. | TTK as tumor marker and therapeutic target for lung cancer |
EP2185732A1 (en) | 2007-07-30 | 2010-05-19 | Oncotherapy Science, Inc. | Cancer associated gene ly6k |
TW201008574A (en) | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
-
2006
- 2006-02-17 ES ES10010439.7T patent/ES2459466T3/es active Active
- 2006-02-17 WO PCT/JP2006/303354 patent/WO2006090810A2/en active Application Filing
- 2006-02-17 EP EP10010439.7A patent/EP2325306B1/en active Active
- 2006-02-17 ES ES06714493T patent/ES2364670T3/es active Active
- 2006-02-17 JP JP2007531118A patent/JP4461179B2/ja active Active
- 2006-02-17 PL PL10010439T patent/PL2325306T3/pl unknown
- 2006-02-17 PL PL10010438T patent/PL2325305T3/pl unknown
- 2006-02-17 PT PT100104389T patent/PT2325305E/pt unknown
- 2006-02-17 EP EP10010438.9A patent/EP2325305B1/en active Active
- 2006-02-17 ES ES10010438.9T patent/ES2459492T3/es active Active
- 2006-02-17 DK DK10010439.7T patent/DK2325306T3/en active
- 2006-02-17 DK DK10010438.9T patent/DK2325305T3/en active
- 2006-02-17 PT PT100104397T patent/PT2325306E/pt unknown
- 2006-02-17 EP EP06714493A patent/EP1853703B1/en not_active Not-in-force
- 2006-02-17 DE DE602006021283T patent/DE602006021283D1/de active Active
- 2006-02-17 US US11/816,616 patent/US7847060B2/en active Active
-
2009
- 2009-03-12 JP JP2009058798A patent/JP4493053B2/ja active Active
- 2009-03-12 JP JP2009058802A patent/JP4493054B2/ja active Active
- 2009-03-12 JP JP2009058801A patent/JP2009173661A/ja active Pending
- 2009-12-25 JP JP2009295766A patent/JP2010143924A/ja active Pending
-
2010
- 2010-10-13 US US12/903,961 patent/US8614176B2/en active Active
-
2011
- 2011-09-30 HK HK11110363.5A patent/HK1156076A1/xx not_active IP Right Cessation
- 2011-09-30 HK HK11110367.1A patent/HK1156077A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2325306A1 (en) | 2011-05-25 |
ES2459492T3 (es) | 2014-05-09 |
EP1853703B1 (en) | 2011-04-13 |
JP2010143924A (ja) | 2010-07-01 |
WO2006090810A3 (en) | 2007-03-29 |
ES2459466T3 (es) | 2014-05-09 |
JP4493053B2 (ja) | 2010-06-30 |
PL2325305T3 (pl) | 2014-07-31 |
EP2325306B1 (en) | 2014-02-12 |
PT2325306E (pt) | 2014-04-29 |
DK2325306T3 (en) | 2014-03-03 |
HK1156076A1 (en) | 2012-06-01 |
JP4493054B2 (ja) | 2010-06-30 |
JP2009173661A (ja) | 2009-08-06 |
PT2325305E (pt) | 2014-04-29 |
US8614176B2 (en) | 2013-12-24 |
US20110027302A1 (en) | 2011-02-03 |
US7847060B2 (en) | 2010-12-07 |
US20090202576A1 (en) | 2009-08-13 |
JP2008530975A (ja) | 2008-08-14 |
PL2325306T3 (pl) | 2014-07-31 |
WO2006090810A2 (en) | 2006-08-31 |
EP2325305B1 (en) | 2014-02-12 |
DK2325305T3 (en) | 2014-03-03 |
JP2009173660A (ja) | 2009-08-06 |
EP1853703A2 (en) | 2007-11-14 |
DE602006021283D1 (de) | 2011-05-26 |
EP2325305A1 (en) | 2011-05-25 |
JP2009173662A (ja) | 2009-08-06 |
JP4461179B2 (ja) | 2010-05-12 |
ES2364670T3 (es) | 2011-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1156076A1 (en) | Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides | |
HK1171026A1 (en) | Peptide vaccines for cancers expressing depdc1 polypeptides depdc1 | |
GB0524788D0 (en) | Polypeptides | |
EG25313A (en) | Improved dry powder inhaler. | |
GB0520794D0 (en) | Inhaler | |
ZA200709046B (en) | Breath actuated inhaler | |
GB0519151D0 (en) | Inhaler | |
IL189899A0 (en) | An inhaler | |
EP1859828A4 (en) | INHALER | |
EP1735335A4 (en) | Cell-destroying peptides | |
IL186880A0 (en) | Evolved interferon alpha polypeptides | |
GB0500677D0 (en) | Dry powder inhaler | |
ZA200610812B (en) | Keratin-binding polypeptides | |
EP1765392A4 (en) | POLYPETPIDES INDUCING APOPTOSIS | |
GB0524194D0 (en) | Respirable powders | |
IL196292A0 (en) | Csf3r polypeptides, their preparation and uses thereof | |
GB0505949D0 (en) | Polypeptides | |
GB0526019D0 (en) | Peptides | |
GB0516527D0 (en) | Peptides | |
GB0403491D0 (en) | Polypeptides, methods and means | |
GB0510091D0 (en) | Inhaler | |
EP1881843A4 (en) | KINASEPEPTIDES AND ANTIBODIES | |
GB0511861D0 (en) | Proteins | |
ATE505536T1 (de) | Peptid-impfstoff für lungenkrebs, der ttk polypeptide exprimiert | |
GB0508866D0 (en) | Soluble polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230217 |